glp 1 users in the us New Health Consumer Mindset and Wallet: From GLP-1s to Trading Up for Health & Longevity The GLP-1 Capitals: Where Weight

poor statin adherence reduced mortality by 35% and that discontinuation increased mortality risk by 90%

Why are GLP-1 medications still not recommended during breastfeeding

supports insulin sensitivity Nervous System: Protects against neurodegeneration and cognitive decline Skin: Improves autoimmune conditions and accelerates wound healing Future Applications of GLP-1 Medications As clinical trials continue, GLP-1 receptor agonists may soon be approved for: Neurodegenerative diseases: Alzheimers, Parkinsons, MS Autoimmune conditions: Psoriasis, RA, Lupus Cardiometabolic syndromes: NAFLD, PCOS, atherosclerosis Pulmonary conditions: Chronic bronchitis, COPD, even long-COVID inflammation Final Thoughts GLP-1 medications are no longer just diabetes or weight loss drugs

Obesity is one of America's most daunting public health challenges

The best place is in the main compartment, towards the back

Diet, food, and nutritional exposures and inflammatory bowel disease or progression of disease: an umbrella review